Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BRI3 binding protein (BRI3BP) is an intracellular protein widely expressed in various tissues, most abundantly in the brain, liver, and kidney. It is localized to the endoplasmic reticulum and mitochondria, where it regulates cellular stress responses and is involved in tumorigenesis, potentially by stabilizing the tumor suppressor protein p53 (TP53). BRI3BP is implicated in cancer biology through protein-protein interactions and may serve as a molecular marker for cancer, although it is not a typical drug target like a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BRI3 binding protein (BRI3BP).